Edwards Lifesciences Corporation (EW)
BMV
Closed
Oct 8, 2026
Day's Range
2,149.2552 wk Range
1,340.70Overview - EW - Edwards Lifesciences Corporation
Key Statistics
Valuation
Enterprise Value
1.26T
P/E (Trailing)
‪72.25‬
PEG Ratio
‪-2.74‬
Price / Sales (TTM)
‪209.26‬
Price / Book
‪115.83‬
EV / EBITDA
‪645.11‬
Profitability
Gross Margin
‪77.46%‬
Profit Margin
‪78.01%‬
Operating Margin
‪21.31%‬
Return on Assets
‪7.83%‬
Return on Equity
‪10.38%‬
Ownership
Shares Outstanding
576.60M
Price stats
50-Day Avg
‪1,529.57‬
200-Day Avg
‪1,481.80‬
Market Cap - EW - Edwards Lifesciences Corporation
Peers - EW - Edwards Lifesciences Corporation
Peer Comparison
Compared with companies in Medical Devices listed on BMV.
- EWBMVEdwards Lifesciences Corporation1.26TMarket Cap+10.77%52-week change72.25P/E (Trailing)‪78.01%‬Profit Margin
- CVXBMVChevron Corporation7.27TMarket Cap+23.33%52-week change20.29P/E (Trailing)‪9.83%‬Profit Margin
- SUNBMVSchneider Electric SE3.26TMarket Cap+9.73%52-week change34.54P/E (Trailing)‪11.27%‬Profit Margin
- ABTBMVAbbott Laboratories3.05TMarket Cap-37.45%52-week change31.66P/E (Trailing)‪11.64%‬Profit Margin
- MDTNBMVMedtronic plc2.02TMarket Cap-8.62%52-week change22.57P/E (Trailing)‪13.93%‬Profit Margin
- SYKBMVStryker Corp.1.82TMarket Cap-42.94%52-week change28.09P/E (Trailing)‪14.43%‬Profit Margin
- ICEBMVIntercontinental Exchange, Inc.1.50TMarket Cap-20.53%52-week change21.23P/E (Trailing)‪38.24%‬Profit Margin
Profile Summary - EW - Edwards Lifesciences Corporation
About
Edwards Lifesciences Corporation is a medical technology company focused on structural heart disease and critical care monitoring. Edwards Lifesciences develops and markets transcatheter aortic valve replacement systems, transcatheter mitral and tricuspid therapies, and surgical structural heart products used to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
